US Antimony Stock Gains Momentum on Strategic Moves and Analyst Confidence
06.01.2026 - 07:54:06Shares of the American mining company US Antimony began the week with notable energy. The increased activity follows a series of corporate developments, including key executive appointments, substantial contract wins, and demonstrated confidence from both company insiders and equity researchers.
The fundamental case for optimism is currently being built in Thompson Falls. The company is bringing new smelting furnaces online at this location, with full operational status targeted for January 2026. This capacity expansion signifies a pivotal shift for the business, moving from a period of significant capital investment toward a phase of substantially increased processing capability. A major strategic advantage is the company's access to high-grade ore from its Stibnite Hill mine, which could reduce reliance on costly third-party purchases and help stabilize profit margins.
Management has set an ambitious sales target of $125 million for the fiscal year 2026. Achieving this goal would represent a tripling of revenue compared to the prior year. The stock was last quoted at $6.91 and has delivered an impressive gain of over 280% across the past twelve months, though it remains well below its October peak of $17.47.
Should investors sell immediately? Or is it worth buying US Antimony?
Leadership Changes and Insider Confidence
A primary catalyst for the recent attention is an internal promotion. Melissa Pagen has been appointed President and Chief Operating Officer of the zeolite division, Bear River Zeolite. Market observers view this move as a logical progression following her substantial contributions. Pagen played an instrumental role in securing two major contracts: a $245 million agreement with the Defense Logistics Agency and a further $106.7 million deal with an industrial partner. These contracts provide significant revenue visibility for the current business year.
In parallel, corporate insiders are showing faith in the company's trajectory. Director Jon R. Marinelli was granted new stock options and restricted stock units. The analyst community has also responded favorably to recent events. Investment bank HC Wainwright raised its price target from $8.50 to $10.25 per share, reaffirming its "Buy" rating. William Blair also initiated coverage on the equity with a positive "Outperform" recommendation.
Execution is Key
The focus now shifts squarely to operational execution. The central questions for investors are whether the new capacity can be brought online as scheduled and if the substantial contracts can be fulfilled profitably. The answers to these questions will be the decisive factor shaping the share price trajectory in the coming months.
Ad
US Antimony Stock: Buy or Sell?! New US Antimony Analysis from January 6 delivers the answer:
The latest US Antimony figures speak for themselves: Urgent action needed for US Antimony investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from January 6.
US Antimony: Buy or sell? Read more here...


